Synthesis and antioxidant, cytotoxicity and antimicrobial activities of novel curcumin mimics

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 2, 2012, Pages 267-274

  Bandgar, Babasaheb P ^a,b   Jalde, Shivkumar S ^b   Korbad, Balaji L ^b   Patil, Sachin A ^b   Chavan, Hemant V ^a   Kinkar, Santosh N ^b   Adsul, Laxman K ^a   Shringare, Sadanand N ^a   Nile, Shivraj H ^b  

^a SOLAPUR UNIVERSITY   (India)

^b SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Antimicrobial; Antioxidant; Curcumin mimics; Cytotoxicity; Xanthine oxidase

Indexed keywords

2 FLUORO N [3 [3 [3 (1,2,3,6 TETRAHYDRO 1 METHYLPYRIDIN 4 YL) 2,4,6 TRIMETHOXYPHENYL]ACRYLOYL]PHENYL]BENZAMIDE; 3 (1,2,3,6 TETRAHYDRO 1 METHYLPYRIDIN 4 YL) 2,4,5 TRIMETHOXYBENZALDEHYDE; 3 AMINOACETOPHENONE; ACETOPHENONE DERIVATIVE; BENZALDEHYDE DERIVATIVE; CURCUMIN; FLAVOPIRIDOL; GEMCITABINE; N [[3 [3 (1,2,3,6 TETRAHYDRO 1 METHYLPYRIDIN 4 YL) 2,4,6 TRIMETHOXYPHENYL]ACRYLOYL]PHENYL]BENZAMIDE; TROLOX C; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BACTERIA; BIOMIMETICS; CELL PROLIFERATION; CURCUMIN; ENZYME INHIBITORS; FUNGI; HUMANS; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; XANTHINE OXIDASE;

EID: 84858125696     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.587416     Document Type: Article

References (46)

1. Boveries A, Cadenas E. Cellular sources and steady-state levels of reactive oxygen species. In Oxygen, Gene Expression and Cellular Functions. Clerch LB, Massaro DJ, (eds.) Marcel Dekkar: New York, 1977; pp. 1-25.
2. Halliwell B, Gutteridge JM. Free Radical in Biology and Medicine, 2nd Edn; Oxford University Press: Clerandon: Oxford, 1989; pp. 1-20.
3. Braughler JM, Duncan LA, Chase RL. Te involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem 1986;261:10282-10289. (Pubitemid 17221964)
4. Abid MR, Schoots IG, Spokes KC, Wu SQ, Mawhinney C, Aird WC. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IκB/NF-κB. J Biol Chem 2004;279:44030-44038. (Pubitemid 39390712)
5. Schiavone JR, Hassan HM. Te role of redox in the regulation of manganese-containing superoxide dismutase biosynthesis in Escherichia coli. J Biol Chem 1988;263:4269-4273. (Pubitemid 18096605)
6. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. Te role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 2000;60:3927-3939. (Pubitemid 32204589)
7. Sorg O. Oxidative stress: A theoretical model or a biological reality? c r Biol 2004;327:649-662. (Pubitemid 38992409)
8. Chow HS, Lynch JJ 3rd, Rose K, Choi DW. Trolox attenuates cortical neuronal injury induced by iron, ultraviolet light, glucose deprivation, or AMPA. Brain Res 1994;639:102-108. (Pubitemid 24067440)
9. Saunders RD, Dugan LL, Demediuk P, Means ED, Horrocks LA, Anderson DK. Efects of methylprednisolone and the combination of α-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 1987;49:24-31. (Pubitemid 17108226)
10. Lamson DW, Brignall MS. Antioxidants in cancer therapy: Teir actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-329. (Pubitemid 29526338)
11. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohof J. Free radicals in cerebral ischemia. Stroke 1978;9:445-447. (Pubitemid 8389070)
12. Gey K F. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 1986;37:53-91.
13. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials. Lancet 2003;361:2017-2023. (Pubitemid 36695043)
14. Ziakas GN, Rekka EA, Gavalas AM, Eleftheriou PT, Kourounakis PN. New analogues of butylated hydroxytoluene as anti-infammatory and antioxidant agents. Bioorg Med Chem 2006;14:5616-5624. (Pubitemid 43994470)
15. Mattson MP. Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003;3:65-94. (Pubitemid 37012494)
16. Stavrovskaya IG, Kristal BS. Te powerhouse takes control of the cell: Is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death? Free Radic Biol Med 2005;38:687-697. (Pubitemid 40249739)
17. Hille R. Structure and Function of xanthine oxidoreductase. Eur J Inorg Chem 2006;10:1913-1926.
18. Pacher P, Nivorozhkin A, Szabó C. Terapeutic efects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87-114.
19. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
20. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol, Cell Physiol 2002;282:C227-C241. (Pubitemid 34663181)
21. Fong JJ, Rhoney DH. NXY-059: Review of neuroprotective potential for acute stroke. Ann Pharmacother 2006;40:461-471.
22. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004;44:97-111. (Pubitemid 38552286)
23. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
24. Park SY, Kim DS. Discovery of natural products from Curcuma longa that protect cells from β-amyloid insult: A drug discovery efort against Alzheimer's disease. J Nat Prod 2002;65:1227-1231.
25. Wahlström B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978;43:86-92. (Pubitemid 9016316)
26. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
27. Rashmi R, Santhosh Kumar TR, Karunagaran D. Human colon cancer cells difer in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 2003;538:19-24. (Pubitemid 36287418)
28. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol 2007;595:471-480.
29. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999;27:486-494.
30. Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 2007;595:453-470.
31. Robinson TP, Ehlers T, Hubbard IV RB, Bai X, Arbiser JL, Goldsmith DJ et al. Design, synthesis, and biological evaluation of angiogenesis inhibitors: Aromatic enone and dienone analogues of curcumin. Bioorg Med Chem Lett 2003;13:115-117. (Pubitemid 35447696)
32. Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang HK, Itokawa H et al. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem 2002;45:5037-5042. (Pubitemid 35278699)
33. Liang G, Yang S, Jiang L, Zhao Y, Shao L, Xiao J et al. Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin. Chem Pharm Bull 2008;56:162-167. (Pubitemid 351206638)
34. Liang G, Li X, Chen L, Yang S, Wu X, Studer E et al. Synthesis and anti-infammatory activities of mono-carbonyl analogues of curcumin. Bioorg Med Chem Lett 2008;18:1525-1529. (Pubitemid 351226515)
35. Bandgar BP, Patil SA, Korbad BL, Nile SH, Khobragade CN. Synthesis and biological evaluation of β-chloro vinyl chalcones as inhibitors of TNF-α and IL-6 with antimicrobial activity. Eur J Med Chem 2010;45:2629-2633.
36. Woo HB, Shin WS, Lee S, Ahn CM. Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity. Bioorg Med Chem Lett 2005;15:3782-3786. (Pubitemid 41043168)
37. Sedlacek HH, Czech J, Naik R, Kaur G, Worland P, Losiewisc M, Parker B, Carlson B, Smith A, Senderowisc A, Sausville EA. Review of chemistry, pharmacology, and antitumor spectrum. Int J Oncol 1996;9:1143-1168.
38. Murthi KK, Dubay M, McClure C, Brizuela L, Boisclair MD, Worland PJ et al. Structure-activity relationship studies of favopiridol analogues. Bioorg Med Chem Lett 2000;10:1037-1041. (Pubitemid 30406461)
39. Hampson LJ, Arden C, Agius L, Ganotidis M, Kosmopoulou MN, Tiraidis C et al. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site. Bioorg Med Chem 2006;14:7835-7845. (Pubitemid 44584712)
40. Naik RG, Kattige SL, Bhat SV, Alreja NJ, De Souza NJ, Rupp RH. An antiinfammatory cum immunomodulatory piperidinylbenzopyranone from dysoxylum binectariferum: Isolation, structure and total synthesis. Tetrahedron 1988;44:2081-2086.
41. Timmegowda NR, Nanjunda Swamy S, Kumar CS, Kumar YC, Chandrappa S, Yip GW et al. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorg Med Chem Lett 2008;18:432-435.
42. Ziakas GN, Rekka EA, Gavalas AM, Eleftheriou PT, Kourounakis PN. New analogues of butylated hydroxytoluene as anti-infammatory and antioxidant agents. Bioorg Med Chem 2006;14:5616-5624. (Pubitemid 43994470)
43. Gaspar A, Garrido EM, Esteves M, Quezada E, Milhazes N, Garrido J et al. New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives. Eur J Med Chem 2009;44:2092-2099.
44. Bandgar BP, Patil SA, Gacche RN, Korbad BL, Hote BS, Kinkar SN et al. Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-infammatory and antioxidant agents. Bioorg Med Chem Lett 2010;20:730-733.
45. Khobragade CN, Bodade RG, Shinde MS, Jaju DR, Bhosle RB, Dawane BS. Microbial and xanthine dehydrogenase inhibitory activity of some favones. J Enzyme Inhib Med Chem 2008;23:341-346. (Pubitemid 351935053)
46. Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH. Development of a propidium iodide fuorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs 1995;6:522-532.